148 related articles for article (PubMed ID: 26949839)
1. CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue.
Etzold A; Galetzka D; Weis E; Bartsch O; Haaf T; Spix C; Itzel T; Schweiger S; Strand D; Strand S; Zechner U
Epigenetics; 2016; 11(2):120-31. PubMed ID: 26949839
[TBL] [Abstract][Full Text] [Related]
2. Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer.
Galetzka D; Hansmann T; El Hajj N; Weis E; Irmscher B; Ludwig M; Schneider-Rätzke B; Kohlschmidt N; Beyer V; Bartsch O; Zechner U; Spix C; Haaf T
Epigenetics; 2012 Jan; 7(1):47-54. PubMed ID: 22207351
[TBL] [Abstract][Full Text] [Related]
3. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients.
Hamam D; Abdouh M; Gao ZH; Arena V; Arena M; Arena GO
J Exp Clin Cancer Res; 2016 May; 35():80. PubMed ID: 27179759
[TBL] [Abstract][Full Text] [Related]
4. Discordant pattern of BRCA1 gene epimutation in blood between mothers and daughters.
Wojdacz TK; Harari F; Vahter M; Broberg K
J Clin Pathol; 2015 Jul; 68(7):575-7. PubMed ID: 25878326
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production.
Salem AF; Howell A; Sartini M; Sotgia F; Lisanti MP
Cell Cycle; 2012 Nov; 11(22):4167-73. PubMed ID: 23047605
[TBL] [Abstract][Full Text] [Related]
6. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
[TBL] [Abstract][Full Text] [Related]
7. Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.
Trylcova J; Busek P; Smetana K; Balaziova E; Dvorankova B; Mifkova A; Sedo A
Tumour Biol; 2015 Aug; 36(8):5873-9. PubMed ID: 25712375
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
9. Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Nikolaienko O; Eikesdal HP; Ognedal E; Gilje B; Lundgren S; Blix ES; Espelid H; Geisler J; Geisler S; Janssen EAM; Yndestad S; Minsaas L; Leirvaag B; Lillestøl R; Knappskog S; Lønning PE
Genome Med; 2023 Dec; 15(1):104. PubMed ID: 38053165
[TBL] [Abstract][Full Text] [Related]
10. Analytical sensitivity of a method is critical in detection of low-level BRCA1 constitutional epimutation.
Machaj F; Sokolowska KE; Borowski K; Retfiński S; Strapagiel D; Sobalska-Kwapis M; Huzarski T; Lubiński J; Wojdacz TK
Sci Rep; 2023 Sep; 13(1):16102. PubMed ID: 37752189
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
12. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
13. Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Schwartz M; Ibadioune S; Vacher S; Villy MC; Trabelsi-Grati O; Le Gall J; Caputo SM; Delhomelle H; Warcoin M; Moncoutier V; Bourneix C; Boutry-Kryza N; De Pauw A; Stern MH; Buecher B; Mouret-Fourme E; Colas C; Stoppa-Lyonnet D; Masliah-Planchon J; Golmard L; Bieche I
Breast; 2024 Feb; 73():103620. PubMed ID: 38096711
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analyses.
Gottschling S; Granzow M; Kuner R; Jauch A; Herpel E; Xu EC; Muley T; Schnabel PA; Herth FJ; Meister M
Lung Cancer; 2013 Apr; 80(1):19-29. PubMed ID: 23294501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers.
Boukerroucha M; Josse C; ElGuendi S; Boujemla B; Frères P; Marée R; Wenric S; Segers K; Collignon J; Jerusalem G; Bours V
BMC Cancer; 2015 Oct; 15():755. PubMed ID: 26490435
[TBL] [Abstract][Full Text] [Related]
16. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells.
Chu TY; Yang JT; Huang TH; Liu HW
Radiat Res; 2014 May; 181(5):540-7. PubMed ID: 24785588
[TBL] [Abstract][Full Text] [Related]
18. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
20. Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma.
Räsänen K; Virtanen I; Salmenperä P; Grenman R; Vaheri A
PLoS One; 2009 Sep; 4(9):e6879. PubMed ID: 19721715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
